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Abstract
Background: Hypertension (HTN) is one of the major causes of cardiovascular morbidity and mortality. The
objective of the study was to investigate the burden and predictors of HTN in India.
Methods: 6120 subjects participated in the Screening and Early Evaluation of Kidney disease (SEEK), a community-based
screening program in 53 camps in 13 representative geographic locations in India. Of these, 5929 had recorded blood
pressure (BP) measurements. Potential predictors of HTN were collected using a structured questionnaire for SEEK study.
Results: HTN was observed in 43.5% of our cohort. After adjusting for center variation (p<0.0001), predictors of a higher
prevalence of HTN were older age ≥40 years (p<0.0001), BMI of≥ 23 Kg/M
2 (p< 0.0004), larger waist
circumference (p< 0.0001), working in sedentary occupation (p <0.0001), having diabetes mellitus (p<0.0001),
having proteinuria (p< 0.0016), and increased serum creatinine (p<0.0001). High school/some college
education (p= 0.0016), versus less than 9th grade education, was related with lower prevalence of HTN. Of note,
proteinuria and CKD were observed in 19% and 23.5% of HTN subjects. About half (54%) of the hypertensive
subjects were aware of their hypertension status.
Conclusions: HTN was common in this cohort from India. Older age, BMI ≥ 23 Kg/M
2,w a i s tc i r c u m f e r e n c e ,
sedentary occupation, education less, diabetes mellitus, presence of proteinuria, and raised serum creatinine
were significant predictors of hypertension. Our data suggest that HTN is a major public health problem in India
with low awareness, and requires aggressive community-based screening and education to improve health.
Keywords: Hypertension, CKD, Awareness
Background
The burden of hypertension varies remarkably throughout
the regions of the world and is a serious public health
problem in both developed and developing countries [1,2].
Both systolic and diastolic hypertension are important
predicting risk factors of cardiovascular disease, chronic
kidney disease and stroke. [3] World Health Organization
(WHO) data indicate that by 2025 the global burden of
hypertension will increase by 60% to be 1.56 billion indi-
viduals worldwide and higher in the developed nations [4].
Lopez et al. have shown that 5.3 million deaths were at-
tributable to cardiovascular disease in the western world
as compared to 8 to 9 million in the developing world [5].
According to a recent report, hypertension was the third
major cause of disease burden, in both developed and de-
veloping regions worldwide, with 64 million disability ad-
justed life years (DALY) [6].
Hypertension is one of the most important modifiable
risk factors for cardiovascular disease (CVD) [7]. Hyper-
tension in early stages does not show any symptoms;
hence many are unaware of its presence. The prevalence
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chronic kidney disease in the US [9,10]. Early detection
is feasible using a simple and accurate screening test and
aggressive blood pressure management. Yet this has not
received adequate attention or allocation of public health
resources for planning effective preventive strategies. In
India, as a developing country with a population esti-
mated at 1.1 billion, the prevalence of hypertension has
been estimated to be 3% to 34.5% in males and 5.8% to
33.5% of females [10-13].
Understanding the burden of hypertension, as a pre-
ventable disease, and underlying risk factors by organizing
population screening is the first step towards planning any
effective preventive programs. The Screening and Early
Evaluation of Kidney Disease (SEEK Study) aimed at gen-
erating epidemiological information on chronic kidney
disease and its associated non-communicable disease in
India. This article presents the results from SEEK Study
on the prevalence and risk factors of hypertension.
Methods
Assembly of the SEEK cohort
Thirteen academic and private medical centers in India
participated in the study under the name of “Screening
and Early Evaluation of Kidney disease- SEEK”.I tw a s
conducted between June 2005 to May 2007, coordinated
from the Brigham and Women’s Hospital in Boston,
Massachusetts. The protocol was approved by the Part-
ner’s Institutional Review Board (IRB) as well as by indi-
vidual centers’ own institutional IRBs in India. Signed or
verbal informed consent (confirmed by a witness) was
obtained before administering the questionnaire, taking
measurements or blood collection. The database is based
at the Brigham and Women’s Hospital.
Geographic distribution of the centers is shown in
Table 1. In general, sampling of subjects from all parts
of India except the Eastern region was achieved. The
camps were conducted in a community-based setting,
and any Indian above the age of 18 years was eligible to
participate in the screening. Participants voluntarily
walked in the screening camp as they noticed the flyer.
Six of the 13 centers screened an exclusive urban popu-
lation, 5 screened an exclusively rural population; and
two screened a mixture. The urban population in our
study comprised 51.2% and 48.8% were rural. Of the
6120 screened subjects, 6047 (98.8%) were adults and
without any prior history of renal replacement therapy
or dialysis. Of these 5929 subjects (98%) had blood pres-
sure measurements, comprising the analysis population
for this article.
Data collection and participant selection
A structured questionnaire translated into local languages
was used (Additional file 1). A team of nephrologists,
nurses, technicians and interviewers participated in the
camps. At every site, staff was trained in interview tech-
niques and measurement of height, weight and blood
pressure by organizing a half day workshop prior to the
camp. Body mass index (BMI) was calculated using
the formula “weight (Kg)/height (M
2).” Overweight
was defined as BMI≥ 23 and<27.5 Kg/M
2,o b e s ea s
BMI≥ 27.5 Kg/M
2 [12]. We also calculated the preva-
lence of being overweight and obese using the conven-
tional cut off of BMI ≥25 Kg/M
2 and ≥30 Kg/M
2
respectively. The waist to hip circumference ratio (WHR)
was calculated by using the waist circumference at the
narrowest circumference between the lower costal margin
and the iliac crest. Hip circumference was measured at
the maximum circumference at the level of the femoral
trochanters. Abdominal obesity was defined as≥90 cms
for males and≥80 cms for females (Asian cut off) [14].
Blood Pressure (BP) measurements
In order to get a standardized BP measurement, a proto-
col per American Heart Association guidelines [15] and
a power-point presentation was provided to the centers,
and staff training on measuring the blood pressure was
carried out prior to camps. Systolic blood pressure (SBP)
was based on the 1st Korotkoff phase and diastolic
(DBP) on the 5th Korotkoff phase. Mercury sphygmo-
manometer was used after checking for zero error. After
rest for 5 minutes, BP was recorded in the sitting position
Table 1 Centers for the SEEK study
Center Screened population
North zone
Himachal Pradesh* 520
Varanasi, Uttar Pradesh* 515
Kanpur, Uttar Pradesh§ 511
Apollo Hospital, Delhi§ 472
RML Hospital, Delhi§ 280
Ludhiana, Punjab§ 402
West-Central zone
Nadiad, Gujarat* 506
Bombay, Maharashtra§ 531
Bhopal, Madhya Pradesh✞✞ 438
South zone
Cochin, Kerala§ 497
H.D.Kote, Karnatak* 1022
Bangalore, Karnatak✞ 275
Vizag, AndhraPradesh* 152
Total 6120
*Centers that screened 100% rural subjects.
§Centers that screened 100% urban subjects.
✞Center screened 73% urban, 27% rural subjects.
✞✞Center that screened 50% each of urban and rural population.
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2 mm using mercury sphygmomanometer. An average of
two readings was taken into consideration.
Laboratory work-up
Non-fasting blood samples were collected in the camps.
Blood was sent to a central laboratory. Quality control
for temperature transporting specimens was checked
and confirmed; i.e., 4–9 degree Celsius. Serum creatinine
was measured using Jaffe Colorimetric method on a
Roche Hitachi 912 analyzer. The instrument was cali-
brated (external calibration) using the Cleveland Clinic
Foundation (CCF) creatinine panel. Regression analysis
was carried out to calculate a formula to convert creatin-
ine values obtained at the SRL-Ranbaxy laboratory (SRL)
to the CCF values as follows: CCF creatinine= −0.13 +
SRL creatinine * 0.99. Urine protein was detected by dip-
stick method (Bayer Multistix 10 SG). A modified MDRD-
3 equation GFR (mL/min/1.73 m
2)=175 × (Scr)
-1.154 ×
(Age)
-0.203 × (0.742 if female) × (1.212 if African Ameri-
can) was used [16]. Plasma glucose was measured by the
glucose oxidase peroxidase method using Roche Hitachi
912 analyzer.
Definition of variables
Urine protein positivity (proteinuria) was defined as
urine protein 1+ or more. Elevated blood pressure (EBP)
was defined as SBP/DBP ≥ 140/90 mmHg [8]. Hyperten-
sion was defined as SBP/DBP ≥ 140/90 mmHg [8] or if
the patient was on medication for hypertension or had a
positive self reported history of hypertension (based on a
response to “have you ever been told that you have high
blood pressure” or ‘a past history of high blood pres-
sure”). Prehypertension was defined as a systolic pres-
sure from 120 to 139 millimeters of mercury (mmHg) or
a diastolic pressure from 80 to 89 mmHg [8]. Diabetes
was defined as fasting blood sugar FBS>126 or non-
fasting blood sugar ≥ 200 or on any medications for dia-
betes mellitus (ADA definition) [17], or if there was a
positive response to the questions “have you ever been
told that you have diabetes” or “past history of diabetes”.
Self reported history of medications was verified and if
the subject did not know the name of the medication
and/or if the stated name was incorrect, the response
was considered as “no” even if the subject’s response to
the question “are you on BP or diabetes medications”
was “yes”. CKD stages were defined using NKF-KDOQI
guidelines (eGFR <60 ml/min/1.73 m
2 or proteinuria ≥
1+ on dipstick) [18]. Self reported ischemic heart disease
was taken as present if there was a self reported history
of a myocardial infarction, percutaneous angioplasty or
coronary artery bypass surgery. Family history included
only first-degree relatives.
Statistical analysis
SAS Statistical Analysis Software Version 9.1.3 (SAS
Institute Inc., Cary, NC, USA) was used. Univariate ana-
lyses comparing distributions of socio-demographic and
clinical/historical measures between HTN groups was
performed first, with comparisons made using Fisher’s
Exact Test and t-tests. Then a multivariate logistic re-
gression model, with HTN yes or no as the outcome,
was fit with variables correlating highly with it univari-
ately (p<0.05). All were entered into the model, and a
stepwise selection process combined with finding a par-
simonious minimum of the Akaike and Schwarz model
information criteria [19] resulted in the final compos-
ition of the model. All covariates are adjusted simultan-
eously for the others including one other covariate,
family history of HTN, which was forced to remain in
the model. Due to the number of variables and the in-
clusion of the center variable interactions were not
tested. We also presented the adjusted odds ratios and
the corresponding 95% confidence intervals for these
resulting relationships.
Results
The main finding of this study is that hypertension
prevalence in our SEEK cohort is 43.5%, and 41.5% of
subjects had blood pressure in the range of “pre-hyper-
tension”. The mean SBP and DBP of the subjects was
126.8(20) and 80.4(11) mmHg respectively (Table 2).
The demographic and clinical history characteristics of
the screened population are shown in Tables 2 and 3.
The mean (SD) age of the screened population was 45.3
(15.2) years and 55% were males. Increasing prevalence
Table 2 Demographic features
Characteristics
HTN-Yes HTN-No p value
(43.5%)
Age n 2578 3351 <.0001
Mean (SD) 52.1(14.02) 40.0(13.93)
BMI n 2561 3340 <.0001
Mean (SD) 25.7(5.37) 22.7(4.87)
Waist circum. n 2426 3236 <.0001
Mean (SD) 88.3(13.33) 79.3(13.12)
Hip circum n 2425 3234 <.0001
Mean (SD) 96.1(12.21) 89.8(11.07)
Systolic BP n 2577 3351 <.0001
Mean (SD) 140.7(19.97) 116(10.99)
Diastolic BP n 2575 3344 <.0001
Mean (SD) 87.7(10.97) 74.8(7.58)
S.Creatinine n 2453 3220 <.0001
Mean (SD) 1.1(1.10) 0.9(0.34)
Boldfaced p values means “statistically significant”.
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60 to 70 years of age having hypertension. In the >
70 years age group there was a higher percentage of fe-
males having HTN. (Figure 1a) Mean BMI, waist and
hip circumference were 24(5.3) Kg/M
2, 83.2(13.9) cm,
and 92.5(12) cm respectively. Forty three percent showed
indications of abdominal obesity. Forty three percent of
the subjects had<8th grade education, 32.1% had “a9 t h
grade to some college” education, and 24.3% had graduate
or postgraduate educations. About one fifth (21.8%) were
involved in manual labor (agricultural workers, laborers,
and cowherds), 33.6% had salaried jobs/ their own busi-
ness, 2.4% were students and 41.3% were involved with
sedentary occupations (homemakers, unemployed, retired
or other occupations), with 63.6% earning less than $125
per month. Another fifth (21.6%) were current smokers or
tobacco chewers; only 2.3% did both. Seventeen percent of
subjects had diabetes (14% self-reported), 21.2% reported
having a family history of HTN, 13.5% had proteinuria,
and 16.3% had CKD. Self reported ischemic heart disease
(heart attack, angioplasty or bypass surgery) was observed
in 5.4% of the subjects, self-reported stroke in 1.3% and
self-reported peripheral vascular disease in 2.4%. Serum
creatinine levels averaged 1.0 mg/dL.
The prevalence of hypertension at various centers is
depicted in Figure 2. Among the rural centers, Kote had
the lowest prevalence of HTN, with the other rural cen-
ters having rates comparable to those in some of the
urban centers. Given that Kote screened 1/3 of the total
rural population, the result of lower rural prevalence
compared to urban prevalence is probably due to Kote,
and highlights the need for center as an adjuster in the
multivariate model.
Only 54% of the HTN subjects were aware of their
hypertension and reported positively to the question
“Have you ever been told that you have high blood
pressure?” or “D oy o uh a v eap a s th i s t o r yo fh y p e r t e n -
sion”. 21.7% of the hypertensive population was on
treatment.
Table 3 Prevalence of risk factors in HTN population
Characteristic Result HTN-Yes HTN-No p-value
N= 2578 N= 3351
n%n%
Age < 40 years 515 20 1701 50.8
≥ 40 years 2063 80 1650 49.2 <0.0001
Gender Female 1095 42.5 1572 46.9
Male 1482 57.5 1779 53.1 0.0007
Education ≤ 8th grade 1011 39.2 1540 46.0
9th to some
college
837 32.5 1069 31.9
College grad/
Post grad
715 27.7 724 21.6 0.0007
Occupation Manual labor* 391 15.2 899 26.8
Own business/
salaried
867 33.6 1128 33.7
Student 18 0.7 122 3.6
Sedentary** 1275 49.5 1171 34.9 0.0007
Income ≤ 125 $/month 1477 57.3 2295 68.5
> 125 $/month 980 38.0 939 28.0 <0.0001
Urabn 1502 58.3 1535 45.8
Rural 1076 41.7 1815 54.2 <0.0001
Obesity status:
Body mass
index✝
<2 3K g / M
2 789 30.6 1904 56.8
≥ 23 Kg/M
2 1772 68.7 1436 42.9 <0.0001
Body mass
index✝✝
<2 7K g / M
2 1709 66.3 2804 83.7
≥ 27 Kg/M
2 852 33.0 536 16.0 <0.0001
Body mass
index✝✝✝
<3 0K g / M
2 2100 81.5 3090 92.2
≥ 30 Kg/M
2 461 17.9 250 7.5 <0.0001
Abdominal No 965 37.4 2149 64.1
Obesity⊙ Yes 1461 56.7 1087 32.4 <0.0001
Current Smoker
or tobacco chewer
No 1875 72.7 2418 72.2
Yes 516 20.0 765 22.8 0.0312
Current Smoker
& tobacco chewer
No 2322 90.1 3054 91.1
Yes 45 1.7 94 2.8 0.0117
Self reported DM No 1892 73.4 2905 86.7
Yes 570 22.1 263 7.8 <0.0001
Diabetes mellitus♦ No 1801 69.9 2862 85.4
Yes 672 26.1 343 10.2 <0.0001
Family H/o HTN No 1967 76.3 2697 80.5
Yes 607 23.5 647 19.3 <0.0001
Urine-protein Absent/trace 2045 79.3 2981 89.0
> = 1+ 489 19.0 310 9.3 <0.0001
CKD♦♦ No 1801 69.9 2814 84.0
Yes 606 23.5 358 10.7 <0.0001
Table 3 Prevalence of risk factors in HTN population
(Continued)
Center type Urban 1355 52.6 1284 38.3
Rural 974 37.8 1618 48.3
Mixed population 249 9.7 449 13.4 0.0051
P value<0.05 is significant.
* - includes categories of occupation – agriculture workers, laborers, cowherds.
** - includes, homemakers (housewives), retired, unemployed and others.
✝ -B o d yM a s sI n d e x-≥ 23 Kg/M
2 includes overweight and obese as per Asian cutoff.
✝✝ - Obese as per Asian cutoff.
✝✝✝ -O b e s ea sp e rc o n v e n t i o n a lc u t o f f .
⊙ - Waist circumference≥90 cms in males or≥80 cms in females.
♦ - Diabetes Mellitus (DM)= Fasting blood sugar≥ 126 or non-fasting blood
sugar≥ 200 or if self reported D.M or on anti diabetic medication.
♦♦- MDRD-GFR<60 ml/min/1.73 m
2 or proteinuria≥1+ on dipstick.
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The mean age of hypertensive subjects was 52.1 years
(SD 14.02 years), significantly higher than the non-
hypertensive subjects (p= <0.0001). Eighty percent of
subjects with HTN were ≥40 years of age as compared
to 49.2% of those without HTN (p<0.0001). Figure 1a
shows increasing prevalence of HTN with age; in the
6
thand 7
th decade ≥70% of males and females in the
screened population had hypertension. The mean sys-
tolic and diastolic blood pressure of the hypertensive
group were 141(20) and 88(11) mmHg respectively,
while that of the non hypertensive group was 116(11)
and 74(8) mmHg respectively (p <0.0001). Approxi-
mately fifty seven percent of subjects with hypertension
were males and to 42.5% were females (p=0.0007). For
the HTN group, the mean BMI was 25.7(5.4) Kg/M
2, the
mean waist circumference was 88.3(13.3) cm, the hip
circumference 96.1(12.2) cm, and 56.7% had abdominal
obesity; these numbers were significantly higher than in
the non-hypertensive group (p <0.0001 for all 4 parame-
ters). There was a significant difference in the distribution
of educational, occupational, and income levels between
the groups, as well as who smoked and/or chewed to-
bacco. Family history of HTN was reported more often in
the HTN group (23.5% vs. 19.3%, p<0.0001).
Confirmed and self-reported diabetes (26.1% and 22.1%,
respectively) were both higher in the HTN group (p<
0.0001). proteinuria was observed among 19% of HTN
subjects as compared to 9.3% of non hypertensive subjects
(p<0.0001). ). CKD (MDRD GFR<60 ml/min/1.73 m
2 or
GFR≥60 ml/min/1.73 m
2 and urine protein≥1+) was
found in 23.5% of HTN subjects and 10.7% of non-
hypertensive subjects (p<0.0001).
A significantly higher prevalence of cardiovascular
complications was observed among subjects with HTN
as compared with those without (see Table 4). Self re-
ported ischemic heart disease (heart attack, angioplasty
or bypass surgery) was observed in 8.9% (p<0.0001),
stroke in 1.9% (p= 0.0002) and peripheral vascular dis-
ease in 3.4% (p =0.005) of HTN subjects, respectively.
Hypertension was significantly higher in the urban
population compared to the rural population (p<0.0001),
and the center distribution showed statistically significant
differences among the three center types (urban, rural,
mixed) (p=0.005).
Predictors of hypertension
We combined the variables described above into a
multivariate model, and this analysis confirmed the indi-
cations of the independent tests. Those greater than
40 years of age were 2.24 times more likely to have HTN
and males 1.17 times more likely to have HTN than fe-
males. This cutoff was chosen after repeated univariate
29.3
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c
Figure 1 Prevalence of Hypertension by Subgroups.
a) Prevalence of HTN by age and gender. b) Prevalence of HTN
among lean/ normal, overweight and obese subjects as defined by
Asian cutoff. c) Risk of HTN among males and females with
abdominal obesity as defined by Asian cutoff.
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largest contrast in HTN prevalence. Continuous mea-
sures of waist circumference retained a positive associ-
ation with HTN (p<0.0001). Having a 9th grade +/some
college education resulted in a lower chance of being
hypertensive (OR: 0.76, 95%CI: 0.64- 0.90, p=0.0016)
compared to having a less than 9th grade education.
Those involved in sedentary (p<0.0001) occupations
versus an agricultural occupation were more likely to
have HTN. Individuals with diabetes were 1.71 times
more likely to become hypertensive, those with protein-
uria 1.40 times more likely, and higher serum creatinine
predisposed one to being hypertensive. Family history of
hypertension was not significantly related to HTN multi-
variately, but was left in the final model (p=0.20).
Table 5 has a complete list of odds ratios and p-values.
The strongest predictors of hypertension were age more
than 40 years, sedentary life style, diabetes, high serum
creatinine, and the presence of urine protein. There was
significant center to center variation in the prevalence of
hypertension when the 12 centers were compared with
the center Bombay (an urban center with 50% preva-
lence of hypertension, (p <0.0001).
Discussion
The main finding of this study is that hypertension preva-
lence in our SEEK cohort is 43.5%, and 41.5% of subjects
had blood pressure in the range of “pre-hypertension”.
The major predictors of hypertension included age >40 years,
male gender, BMI of≥23 Kg/M
2, waist circumference,
sedentary occupation, proteinuria, and increased serum
creatinine, proteinuria and CKD were observed in 19%
and 23.5% of HTN subjects, respectively. Nearly two-
thirds of the cohort with hypertension was overweight or
obese compared to only approximately 40% of those with-
out HTN. Collectively, these observations support the idea
that hypertension is an important public health issue in
developing countries and it has important associations
with both kidney disease and obesity. In China, the largest
and most populous country in Asia, HTN was identified
as the major causes of death [20-22].
Both Asia and Africa are witnessing this increasing
prevalence due to acculturation. Rapid and often uncon-
trolled urbanization leads to exposure to many health
risks, including poor sanitation and environmental risk
factors. However, it also leads to changes in dietary and
lifestyle changes leading to decreased physical activity
and increased risk of obesity and greater risk of hyper-
tension. Most of the increase in the prevalence of HTN
in the developing countries especially in the South East
Asia has been attributed to the increase in obesity [23].
55
66.7
41
49
17.3
38
35.6
50
60
51.5
45
56
0
10
20
30
40
50
60
70
80
%
Rural 
Mixed
Urban
Figure 2 Prevalence of hypertension by center.
Table 4 Cardiovascular Disease in the SEEK Cohort (self
reported history)
Characteristics HTN Yes HTN No Total population p-value
N= 2578 N=3351 N = 5929
n%n% n %
Ischemic heart
disease*
229 8.9 90 2.7 319 5.4 <0.0001
Stroke 50 1.9 27 0.8 77 1.3 0.0002
Peripheral vascular
disease
87 3.4 57 1.7 144 2.4 0.0051
*Self reported positive history of heart attack, angioplasty or coronary
by-pass operation.
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the rural populations has been also shown in several
other studies [24-26] including a recent meta-analysis
[27]. It showed that the prevalence of HTN varied be-
tween 4.5 to 45% in rural populations, and a higher
prevalence (13.9–48.2%) in the urban populations, with
a significant increasing trend over time.
Excess body weight has been identified as an import-
ant independent risk factor for hypertension and related
complications of CVD [28]. Several reports suggest that
among the Chinese and South Asian population a higher
prevalence of dyslipedemia, metabolic syndrome, type II
diabetes mellitus and CVD are observed at a much lower
value of BMI than the Europeans [28,29]. The normal
range of BMI cutoff points derived in the western
population may be misleading when used for these eth-
nic groups [29]. An Asian cut off for obesity and abdom-
inal obesity among different ethnic populations was also
defined by the International Diabetes Federation consen-
sus group in 2004 [17]. This cut-off was much lower for
the Chinese, Japanese, South Asian population as com-
pared to the European population [30]. He et al. ob-
served that waist circumference adds additional risk
information to that of BMI in Chinese adults [31]. Obes-
ity by conventional standards (17.9%) and Asian stan-
dards (33%) was prevalent among HTN subjects.
However, 68.7% of the HTN population was overweight
or obese compared to 42.9% of those without HTN. Fur-
ther, we observed overweight or obese (BMI ≥ 23 Kg/
M
2) individuals to have 1.37 times higher prevalence of
HTN compared to those with lean or normal BMI (< 23
Kg/M
2). In the KEEP study, 50.8% of HTN subjects were
obese using the conventional cut off [32] Also, waist cir-
cumference as a continuous variable revealed a signifi-
cantly higher positive association with HTN. Given the
propensity of Indian population to develop hypertension
at a much lower body weight and waist circumference,
urgent and concerted prevention policy development
and implementation including educational intervention
for improving diet and exercise is necessary.
Association of HTN with diabetes mellitus, proteinuria
and CKD was high in our cohort. Kidney disease can be
the cause or consequence of hypertension. Proteinuria is
the earliest indication of kidney disease among diabetic
subjects and has been observed in about 20- 40% of dia-
betic subjects without known kidney disease [33,34]. But
prevalence of albuninuria among hypertensive individ-
uals screened in large populations has been reported in
8–11.5% in the AusDIAB and Prevention of Renal and
Vascular End Stage Disease (PREVEND) studies [35-37].
The relationship between hypertension and proteinuria
has however not been explored in many epidemiologic
studies reported from India [10,12,13]. Since these were
screening camps, and the fact the renal involvement can
be a cause or effect of hypertension, it is difficult to as-
sess if the renal involvement is a predictor or a compli-
cation of HTN in our cohort. However, it is important
to note this association was observed in a significant
number of subjects in the cohort. With adequate man-
agement of both HTN and proteinuria, further compli-
cations of CVD, retinopathy as well as ESRD can be
prevented. Training general practitioners to carry out a
simple urine dip-stick test among hypertensive and dia-
betic subjects would help in detecting these cases early
and preventing the progression.
Despite the design of the study wherein a bias may
exist for more people with higher awareness of HTN to
come to attend the screening camps, we observed a low
awareness and control of HTN. Our study demonstrates
Table 5 Multi-variate regression analysis for association
of risk factors with HTN (adjusted for all characteristics
with p value<0.05 on univariate analysis)
Variable Adjusted odds ratio p-value
>= 40 years
2.24 (1.93- 2.59) <0.0001
(ref: less than 40 years)
Male
1.17 (1.00- 1.38) 0.0564
(ref: female)
9th Grade/Some College
0.76 (0.64- 0.90) 0.0016
(ref: less than 9th grade)
College Grad/Post Grad
0.85 (0.70- 1.04) 0.1159
(ref: less than 9th grade)
Own Business/Salaried
1.07 (0.87- 1.32) 0.5149
(ref: unemployed)
Student
0.80 (0.43- 1.48) 0.4751
(ref: unemployed)
Sedentary*
1.79 (1.45- 2.20) <0.0001
(ref: physical job)
BMI>=23 kg/m^2
1.37 (1.15- 1.64) 0.0004
(ref: BMI less than 23)
Waist Circumference
1.03 (1.03- 1.04) <0.0001
(ref: normal WC)
Diabetes Mellitus♦
1.71 (1.44- 2.04) <0.0001
(ref: no DM)
Family History of HTN
1.11 (0.95-1.31) 0.1963
(ref: No FH of HTN)
Serum Creatinine
1.61 (1.34- 1.93) <0.0001
(ref: normal creatinine)
Urine protein> = 1+
1.40 (1.14- 1.73) 0.0016
(ref: no urine protein)
p value < 0.05 significant,
*Includes, homemakers (housewives), retired, unemployed and others.
♦Diabetes Mellitus (DM)= fasting blood sugar ≥126 or non-fasting blood
sugar ≥ 200 or if self reported D.M or on ant diabetic medication.
Serum creatinine and waist circumference are taken as a continuous variable.
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the USA by Burt et al., an awareness rate of 73% in the
National Health and Nutrition Examination Surveys
(NHANES III-1988 –1991, [38,39]. Low awareness of
HTN may reflect disparities in health care access, lack of
education, the effect of poverty, or a combination of
these and other factors. Low awareness of HTN has
been observed in other developing countries including
China and Pakistan [40-42]. In part, this is because of
the low level of literacy and education, but also seems to
reflect low level of access to medical care. Indeed, in
South Asian countries, awareness correlated with poor
access to treatment and therefore to control of hyperten-
sion [42]. The challenge posed by low level of awareness
must be overcome for prevention through strategies tar-
geted at education and promotion. This lack of aware-
ness underscores the importance of organizing an
aggressive community based screening as well as health
education campaign to improve awareness of morbidity
and mortality due to HTN among the population.
Greater commitment and availability of resources tar-
geted at health education will likely to be needed.
Our findings indicate that prevalence of HTN was
high in the screened population at 43.5%, with signifi-
cant center to center variation in prevalence. This effect
was observed independently of other risk factors for
hypertension and could perhaps reflect regional differ-
ences in salt intake and/or other lifestyle practices. The
fact that HTN increased with age and was higher for
males was consistent with other reports [43,44]. In the
meantime, the prevalence of hypertension of the SEEK
study that we carried out in Thailand and Saudi Arabia
were found to be 27.5% and 27.7% [45,46].
Our higher prevalence of HTN compared to some of
the other reported series from India and other Asian
countries like Pakistan and China may be related to the
design of the study (camp module) as opposed to the
domiciliary screening method used by others [4,13,42].
These differences in prevalence may also be related to
the instrument used for the measurement of BP, the def-
inition of hypertension used, and the genetic/anthropo-
logic make up of the population screened. The findings
also corroborate those by Keraney et al. where they re-
ported that the “Global burden of Hypertension” will
affect more than a quarter of the world’s adult popula-
tion with HTN in 2000, and was projected to be in-
creased by 60% by about 2025, the population burden
being higher in the developing countries [4].
High prevalence of pre-hypertension (41.5%) in the
screened population is also worrisome. A collaborative
meta-analysis of individual participant data from one
million adults with no previous vascular disease re-
corded at baseline in 61 prospective observational stud-
ies of blood pressure and mortality during 12.7 million
person-years at risk was analyzed. The authors observed
that throughout middle and old age, blood pressure is
strongly and directly related to vascular (and overall)
mortality, without any evidence of a threshold down to
at least 115/75 mmHg [47]. The Trial Of Preventing
Hypertension (TROPHY) also echoed the same observa-
tions that the CVD risk begins to rise even before the
diagnosis of HTN is made [48]. The JNC 7 calls for rou-
tine blood pressure measurement at least once every
2 years for adults with pre-hypertension [8] and the
American Heart Association issued similar recommen-
dations for adults beginning at age 20 years for primary
prevention of hypertension [49]. Surveillance of this pre-
HTN population particularly among those >40 years of
age for early detection of HTN will be essential.
This study had strengths and limitations. Its major
strengths were the large sample size and the national
distribution of health screening camps, although we did
not have representation in the eastern parts of India. We
believe that training of staff and use of standardized
measurements also reduced the possibility of measure-
ment bias. The main limitation was that we used a camp
based methodology for screening rather than domiciliary
screening and this may bias in favor of higher rates of
disease. Nevertheless, our data adds information on risk
factors, the burden of hypertension in the population.
Further, this method has been used successfully as a cost
effective method of detecting positive cases for screening
large populations in the USA for the prevalence of CKD,
hypertension and diabetes in the KEEP study [32]. An
average of two measurements at a single visit is consid-
ered acceptable for an epidemiologic study using screen-
ing camps methodology and has been used by other
surveys in the USA and other countries [28,50]. We de-
fined HTN as EBP/self reported medications for HTN/
self reported HTN as a positive answer to the question
“have you ever been told that you have HTN”. This dif-
fers from the definition used by some of the previously
reported studies that define HTN as EBP and/or self re-
ported medications for HTN. A single spot urine sample
and absence of quantification of albuminuria was also a
limitation.
Conclusions
In conclusion, HTN is an important public health prob-
lem in India. Reliable information about the prevalence
of HTN is germane to the planning of any preventive or
therapeutic strategies for HTN in a community. Low
level of awareness and control in the HTN population
makes it imperative to bring about a change in the way
health related education should be brought to this popu-
lation. An emphasis on education that is related to the
control of modifiable predictors of hypertension, such as
reducing obesity and abdominal obesity by diet and
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in sedentary occupations) should be considered. Limiting
salt consumption coupled with other lifestyle changes
are likely to be one of the cost-effective population-
based strategies and need to be considered as part of the
public health agenda in India. If scarce resources are to
be utilized optimally, control of HTN will help in im-
proving the management of both CVD and CKD.
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